Mg. Cherian et al., CONTEMPORARY-ISSUES IN TOXICOLOGY - ROLE OF METALLOTHIONEIN IN CARCINOGENESIS, Toxicology and applied pharmacology, 126(1), 1994, pp. 1-5
Metallothionein (MT) is a low-mo-lecular-weight protein (6800 Da) and
one-third of its amino acids are cysteine residues. The 20 cysteines c
oordinate 7 metal atoms (zinc, copper, and/or cadmium). This protein i
s extremely inducible by metals as well as a number of organic compoun
ds. MT is thought to be an important intracellular storage site for zi
nc and possibly other essential trace elements. In addition, tolerance
to cadmium toxicity is often due to the induction of MT, which seques
ters cadmium and lowers its concentration at critical intracellular si
tes. Recently it has been proposed that MT might play important roles
in several aspects of the carcinogenic process. In this context a symp
osium was held recently on this topic at the 1993 Annual Society of To
xicology Meeting. At this symposium Dr. Cherian discussed the expressi
on of MT in various human tumors and its use as a potential marker of
tumor differentiation or cell proliferation. Dr. Imura provided data i
llustrating that induction of MT can be used as an adjunct in cancer c
hemotherapy, in preventing toxicity caused by gamma-irradiation or cis
platin (CDDP) and other chemotherapeutics. Induction of MT has been su
ggested to be an important mechanism of resistance of tumor cells to c
hemotherapeutic agents, such as CDDP. This is controversial, and vario
us views on this topic were presented by Drs. Howell, Late, and Koropa
tnick. Dr. Waalkes then discussed the role of MT in the carcinogenic a
nd anticarcinogenic effects of metals. (C) 1994 Academic Press, Inc.